Exercise for Oncology Care Professionals

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMelanie Keats

About this trial

The goal of this preference-based pilot study will be to assess the feasibility and acceptability, and impact of a 12-week exercise intervention on oncology care provider burnout. Participants self-select to participate into one of two exercise groups. Group assignment will be based on participant preference.

Group 1: Supervised circuit-based resistance exercise

Group 2: Nature-based walking

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

18 years of age or older;

Able to speak/write in English;

Must be providing formal care to cancer patients in a clinical setting within the Halifax Municipality;

Actively practicing within the Nova Scotia Cancer Care Program; and

Disqualifiers

Exceeding Canadian physical activity guidelines of 150-minutes of moderate-to-vigorous physical activity per week; and

Any health condition that would preclude safe participation in a new exercise program.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Circuit-based Resistance Training

    Behavioral

    Participants will engage in a 12-week circuit-based resistance training program 2-3 times/week. Each supervised session will last about 30 minutes and will consist of 5 resistance exercises. Each exercise will be completed for 1 minute for a total of 5 minutes followed by a 1-minute rest. The circuit will then repeated 3 additional times (total of 4 circuits). All resistance sessions will be supervised by a certified fitness professionals.

  • Nature-based Walking

    Behavioral

    Participants will be asked to engage in 30 minutes of self-paced walking in nature 2-3 days/week. Participants will be provided with a list of resources that direct them to walkable nature/green spaces close to their home or workplace.

Treatment groups

70 Participants
are divided into 2 treatment groups
Group A: Circuit-based resistance exerciseExperimental treatment 1 intervention
Group B: Nature WalkingActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Feasibility - Participant Fidelity (Intervention Adherence)

Participant adherence to prescribed exercise intervention

Time frame
Through study completion (about 2 years)
2

Feasibility - Safety

Adverse and serious adverse events

Time frame
Through study completion (about 2 years)
3

Feasibility - Retention/Attrition

Percentage of participants who complete the 12-week intervention

Time frame
Through study completion (about 2 years)
4

Feasibility - Attendance

Attendance is calculated as the percentage of exercise sessions completed by the total number of available exercise sessions over the 12-week intervention.

Time frame
Through study completion (about 2 years)

Secondary outcomes

1

Maslach Burnout Inventory (MBI) for Medical Personnel (MP)

The MBI-MP is used to assess burnout in medical professionals. The 22-item, 7-point Likert scale (0 = never to 6 = everyday) assesses burnout across three dimensions: emotional exhaustion (9 items), personal accomplishment (8 items), and depersonalization (5-items).

Time frame
Baseline, mid-program (6-weeks), and post intervention (12-weeks).
2

Physical Activity Behavior - Self-reported

Self-reported physical activity is assessed by the Godin Leisure Time Exercise Questionnaire. Higher scores indicate higher levels of physical activity. Participants reporting moderate-to-strenuous Leisure Score Index ≥ 24 are classified as active; those reporting moderate-to-strenuous Leisure Score Index ≤ 23 are classified as insufficiently active.

Time frame
Baseline, mid-program (6-weeks), and post intervention (12-weeks).
3

Resting heart rate

Resting heart rate

Time frame
Pre to post intervention (12-week change)
4

Resting Blood Pressure

Resting systolic and diastolic blood pressure

Time frame
Pre to post intervention (12-week change)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Melanie Keats

Lead sponsor

Nova Scotia Health Authority

Sponsor institution